Fir Tree Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Fir Tree Capital Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-230,111	Closed	-$2.49M	–	233
2023 Q3	$2.49M	Buy	230,111 +13,546	+6%	+$145K	0.26%	133
2023 Q2	$2.31M	Sell	216,565 -6,035	-3%	-$63.5K	0.21%	163
2023 Q1	$2.32M	Sell	222,600 -21,424	-9%	-$222K	0.18%	177
2022 Q4	$2.51M	Sell	244,024 -4,576	-2%	-$46.4K	0.13%	225
2022 Q3	$2.5M	Hold	248,600	–	–	0.08%	317
2022 Q2	$2.5M	Sell	248,600 -100	-0%	-$993	0.08%	330
2022 Q1	$2.46M	Buy	+248,700	New	+$2.45M	0.07%	346

Fir Tree Capital Management's BIOS Position: Q4 2023 in Review

Fir Tree Capital Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 230,111 shares — an estimated $2.49M sold.

Fir Tree Capital Management first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $2.51M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Fir Tree Capital Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Fir Tree Capital Management sold 230,111 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.49M.
Fir Tree Capital Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Fir Tree Capital Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $2.51M in Q4 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Fir Tree Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.